Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Apr 16, 2023; 11(11): 2521-2527
Published online Apr 16, 2023. doi: 10.12998/wjcc.v11.i11.2521
Published online Apr 16, 2023. doi: 10.12998/wjcc.v11.i11.2521
SMARCA4-deficient undifferentiated thoracic tumor: A case report
Hee Jung Kwon, Min Hye Jang, Department of Pathology, Yeungnam University Medical Center, Daegu 42415, South Korea
Author contributions: Kwon HJ and Jang MH contributed to manuscript writing and editing and data collection; Kwon HJ contributed to data analysis; Jang MH contributed to conceptualization and supervision; all authors have read and approved the final manuscript.
Supported by a grant from Yeungnam University , No. 222A580017 .
Informed consent statement: The study protocol was approved by the Institutional Review Board of the Yeungnam University Medical Center with a waiver of informed consent.
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript has been prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Min Hye Jang, MD, PhD, Assistant Professor, Department of Pathology, Yeungnam University Medical Center, 170, Hyeonchung-ro, Nam-gu, Daegu 42415, South Korea. clodious@ynu.ac.kr
Received: December 20, 2022
Peer-review started: December 20, 2022
First decision: February 17, 2023
Revised: February 27, 2023
Accepted: March 22, 2023
Article in press: March 22, 2023
Published online: April 16, 2023
Processing time: 107 Days and 3.5 Hours
Peer-review started: December 20, 2022
First decision: February 17, 2023
Revised: February 27, 2023
Accepted: March 22, 2023
Article in press: March 22, 2023
Published online: April 16, 2023
Processing time: 107 Days and 3.5 Hours
Core Tip
Core Tip: SMARCA4-deficient undifferentiated tumors are highly aggressive neoplasms. Here, we report a case of a SMARCA4-deficient undifferentiated tumor with characteristic clinical and histological features. The findings of this case could serve as a resource for future studies.